C A Dionne
Overview
Explore the profile of C A Dionne including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
1408
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jaye M, Dionne C
Methods Mol Biol
. 2011 Mar;
15:89-94.
PMID: 21400267
The polymerase chain reaction (PCR) approach to chromosome assignment consists of analyzing the profile of specific amplification products of the gene of interest using genomic DNAs from a panel of...
2.
Weeraratna A, Dalrymple S, Lamb J, Denmeade S, Miknyoczki S, Dionne C, et al.
Clin Cancer Res
. 2001 Aug;
7(8):2237-45.
PMID: 11489797
During the progression of prostate cancer, molecular changes occur resulting in the autocrine production of a series of neurotrophins by the malignant cells. This is coupled with expression of high-affinity...
3.
Evans A, Kisselbach K, Yamashiro D, Ikegaki N, Camoratto A, Dionne C, et al.
Clin Cancer Res
. 1999 Dec;
5(11):3594-602.
PMID: 10589776
Neuroblastoma (NBL) and medulloblastoma (MBL) are tumors of the neuroectoderm that occur in children. NBL and MBL express Trk family tyrosine kinase receptors, which regulate growth, differentiation, and cell death....
4.
Goldmacher V, Bartle L, Skaletskaya A, Dionne C, Kedersha N, Vater C, et al.
Proc Natl Acad Sci U S A
. 1999 Oct;
96(22):12536-41.
PMID: 10535957
Human cytomegalovirus (CMV), a herpesvirus that causes congenital disease and opportunistic infections in immunocompromised individuals, encodes functions that facilitate efficient viral propagation by altering host cell behavior. Here we show...
5.
Miknyoczki S, Chang H, Klein-Szanto A, Dionne C, Ruggeri B
Clin Cancer Res
. 1999 Sep;
5(8):2205-12.
PMID: 10473107
The aggressive behavior and poor prognosis of pancreatic ductal adenocarcinoma (PDAC) is associated with an increased expression of many growth factors and their cognate receptors. We have previously demonstrated the...
6.
Miknyoczki S, Dionne C, Klein-Szanto A, Ruggeri B
Ann N Y Acad Sci
. 1999 Jul;
880:252-62.
PMID: 10415871
The survival rate for patients with pancreatic ductal adenocarcinoma (PDAC) is among the poorest for all cancers. The factors that contribute to this poor prognosis are lack of effective early...
7.
George D, Dionne C, Jani J, Angeles T, Murakata C, Lamb J, et al.
Cancer Res
. 1999 May;
59(10):2395-401.
PMID: 10344749
The indolocarbazole analogue CEP-751 is a potent and selective tyrosine kinase inhibitor of the neurotrophin-specific trk receptors that has demonstrated antitumor activity in nine different models of prostate cancer growth...
8.
Miknyoczki S, Lang D, Huang L, Klein-Szanto A, Dionne C, Ruggeri B
Int J Cancer
. 1999 Apr;
81(3):417-27.
PMID: 10209957
The aggressive and highly metastatic behavior observed in pancreatic ductal adenocarcinoma (PDAC) may be due to autocrine and/or paracrine interactions (tumor/stromal) involving altered expression of peptide growth factors and their...
9.
Yasuda M, Han J, Dionne C, Boyd J, Chinnadurai G
Cancer Res
. 1999 Feb;
59(3):533-7.
PMID: 9973195
Apoptosis is regulated by interaction of viral and cellular BCL-2 family antiapoptotic proteins with various pro-apoptotic proteins, several of which are also members of the BCL-2 family. Cellular protein BNIP3...
10.
Dionne C, Camoratto A, Jani J, Emerson E, NEFF N, Vaught J, et al.
Clin Cancer Res
. 1998 Aug;
4(8):1887-98.
PMID: 9717816
Advanced prostate cancer remains largely incurable, primarily because the very low growth fraction present in these tumors makes them generally resistant to treatment with standard chemotherapeutic agents that target cell...